Aptar Pharma and Macquarie University partner on drug delivery project
Pharmaceutical Technology·
Bank of America Corp DE Takes Position in AptarGroup, Inc. $ATR
Market Beat·- Bank of America Corp DE purchased 401,624 shares of AptarGroup, Inc. valued at approximately $50,283,000 during the second quarter. - AptarGroup reported quarterly earnings of $1.42 per share with revenue of $1.03 billion, outperforming analyst estimates. - Several institutional investors and hedge funds also adjusted their holdings in AptarGroup, which currently holds a consensus moderate buy rating.Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance
Pharmaceutical Technology·